Literature DB >> 25481738

Precise construction of oligonucleotide-Fab fragment conjugate for homogeneous immunoassay using HaloTag technology.

Henna Päkkilä1, Riikka Peltomaa2, Urpo Lamminmäki2, Tero Soukka2.   

Abstract

The use of oligonucleotide-protein conjugates enables the development of novel types of bioanalytical assays. However, convenient methods for producing covalent and stoichiometric oligonucleotide-protein conjugates are still rare. Here we demonstrate, for the first time, covalent conjugation of DNA oligonucleotide to Fab fragments with a 1:1 ratio using HaloTag self-labeling technology. The oligonucleotide coupling was carried out while the Fab was attached to protein G matrix, thereby enabling straightforward production of covalent conjugates. Furthermore, it allowed convenient purification of the product because the unreacted components were easily removed before the elution of the high-purity conjugate. The prepared conjugate was employed in a homogeneous immunoassay where prostate-specific antigen was used as a model analyte. Switchable lanthanide luminescence was used for detection, and the obtained limit of detection was 0.27 ng/ml. In the future, the developed method for covalent conjugation and successive purification in protein G column could also be applied for introducing other kinds of modifications to Fab fragments in a simple and site-specific manner.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioconjugation; Homogeneous detection; Immunoassay; Lanthanide chelate

Mesh:

Substances:

Year:  2014        PMID: 25481738     DOI: 10.1016/j.ab.2014.11.018

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Antibody microarrays utilizing site-specific antibody-oligonucleotide conjugates.

Authors:  Erik D Wold; Ryan McBride; Jun Y Axup; Stephanie A Kazane; Vaughn V Smider
Journal:  Bioconjug Chem       Date:  2015-04-30       Impact factor: 4.774

Review 2.  HaloTag technology: a versatile platform for biomedical applications.

Authors:  Christopher G England; Haiming Luo; Weibo Cai
Journal:  Bioconjug Chem       Date:  2015-05-22       Impact factor: 4.774

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.